Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 846-852

  Tran Thang C ^a,d   Kruithof, E K O ^b   Lahm, H ^a   Schuster, W A ^a   Tada, M ^c   Sordat, B ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d U de Pathol Exp   (Switzerland)

Author keywords

Cytokine receptor; Interleukin 1 ; Interleukin 6; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UROKINASE;

ARTICLE; CARCINOMA CELL; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0029781670     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.447     Document Type: Article

References (54)

1. BALKWILL F, BURKE F, TALBOT D, TAVERNIER J, OSBORNE R, NAYLOR S, DURBIN H AND FIERS W. (1987). Evidence for tumour necrosis factor/cachectin production in cancer. Lancet, 2, 1229-1232.
2. BEISSERT S, BERGHOLZ M, WAASE I, LEPSIEN G, SCHAUER A, PFIZENMAIER K, AND KRÖNKE M. (1989). Regulation of tumor necrosis factor gene expression in colon adenocarcinoma: in vivo analysis by in situ hybridization. Proc. Natl Acad. Sci. USA, 86, 5064-5068.
3. BIGDA J, BELETSKY I, BRAKEBUSCH C, VVARFOLOMEEV Y, ENGELMANN H, BIGDA J, HOLTMANN H AND WALLACH D. (1994). Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med., 180, 445-460.
4. CAJOT JF, KRUITHOF EKO, SCHLEUNING WD, SORDAT B AND BACHMANN F. (1986). Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int. J. Cancer. 38, 719-727.
5. COLOMBO MP, MACCALLI C, MATTEI S, MELANI C, RADRIZZANI M AND PARMIANI G. (1992). Expression of cytokine genes, including IL-6 in human malignant melanoma cell lines. Melanoma Res., 2, 181-189.
6. DEYERLE KL, SIMS JE, DOWER SK AND BOTHWELL MA. (1992). Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J. Immunol., 149, 1657-1665.
7. DING AH AND PORTEU F. (1992). Regulation of tumor necrosis factor receptors on phagocytes. Proc. Soc. Exp. Biol. Med., 200, 458-465.
8. DINGEMANS KP, ZEEMAN-BOESCHOTTEN IM, KEEP RF AND DAS PK. (1993). Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int. J. Cancer, 54, 1010-1016.
9. ERICKSON SL, DE SAUVAGE FJ, KIKLY K, CARVER-MOORE K, PITTS-MEEK S, GILLETT N, SHEEHAN KCF, SCHREIBER RD, GOEDDEL DV AND MOORE MW. (1994). Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature, 372, 560-563.
10. GAFFNEY EV, KOCH G, TSAI S-C, LOUCKS T AND LINGENFELTER SE. (1988). Correlation between human cell growth response to interleukin 1 and receptor binding. Cancer Res., 48, 5455-5459.
11. GANESH S, SIER CFM, GERRIT GRIFFIOEN JM, VLOEDGRAVEN HJM, DE BOER A, WELVAART K, VAN DE VELDE CJH, VAN KRIEKEN JHJM, LAMERS CBHW AND VERSPAGET HW. (1994). Prognostic relevance of plasminogen activators and their inhibitors in colon cancer. Cancer Res., 54, 4065-4071.
12. GEORG B, HELSETH E, LUND LR, SKANDSEN T, RICCIO A, DANO K, UNSGAARD G AND ANDREASEN PA. (1989). Tumor necrosis factor-α regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines. Mol. Cell. Endocrinol., 61, 87-96.
13. HASDAY JD, SHAH EM AND LIEBERMAN AP. (1990). Macrophage tumor necrosis factor-α release is induced by contact with some tumors. J. Immunol., 145, 371-379.
14. HEALY AM AND GELEHRTER TD. (1994). Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. J. Biol. Chem., 269, 19095-19100.
15. HEINRICH PC, CASTELL JV AND ANDUS T. (1990). Interleukin-6 and the acute phase response. Biochem. J., 265, 621-636.
16. HELLER RA AND KRÖNKE M. (1994). Tumor necrosis factor-mediated signaling pathways. J. Cell Biol., 126, 5-9.
17. HEUSSEN C AND DOWDLE EB. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem., 102, 196-202.
18. IMAMURA K, SPRIGGS D AND KUFE D. (1987). Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. J. Immunol., 139, 2989-2992.
19. JUNG HC, ECKMANN L, YANG SK, PANJA A, FIERER J, MORZYCKA-WROBLEWSKA E AND KAGNOFF MF. (1995). A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest., 95, 55-65.
20. LEVINE S AND SALTZMAN A. (1990). Lymphatic metastases from the peritoneal cavity are increased in the postinflammatory state, Inv. Metast., 10, 281-288.
21. LOETSCHER H, PAN YCE, LAHM HW, GENTZ R, BROCKHAUS M, TABUCHI H AND LESSLAUER W. (1990). Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell, 61, 351-359.
22. LOSKUTOFF DJ. (1991). Regulation of PAI-1 gene expression. Fibrinolysis, 5, 197-206.
23. MANTOVANI A, BOTTAZZI B, COLOTTA F, SOZZANI S AND RUCO L. (1992). The origin and function of tumor-associated macrophages. Immunol. Today, 13, 265-270.
24. MARSHALL, BC, XU QP, RAO NV, BROWN BR AND HOIDAL JR. (1992). Pulmonary epithelial cell urokinase-type plasminogen activator induction by interleukin-1β and tumor necrosis factor-α. J. Biol. Chem., 267, 11462-11469.
25. MASURE S AND OPDENAKKER G. (1989). Cytokine-mediated proteolysis in tissue remodelling. Experientia, 45, 542-549.
26. MATTEI S, COLOMBO MP, MELANI C, SILVANI A, PARMIANI G AND HERLYN M. (1994). Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer, 56, 853-857.
27. MCMAHAN CJ, SLACK JL, MOSLEY B, COSMAN D, LUPTON SD, BRUNTON LL, GRUBIN CE, WIGNALL JL, JENKINS NA, BRANNAN CI, COPELAND NG, HUEBNER K, CROCE CM, CANNIZZARRO LA, BENJAMIN D, DOWER SK, SPRIGGS MK AND SIMS JE. (1991). A novel IL-1 receptor, cloned from B cells by mammalian expression is expressed in many cell types. EMBO J., 10, 2821-2832.
28. MEDCALF RL, KRUITHOF EKO AND SCHLEUNING WD. (1988). Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor cachectin-responsive genes. J. Exp. Med., 168, 751-759.
29. MILES DW, HAPPERFIELD LC, NAYLOR MS, BORROW LG, RUBENS RD AND BALKWILL FR. (1994). Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue. Int. J. Cancer, 56, 777-782.
30. NAKAZAKI H. (1991). Preoperative and postoperative cytokines in patients with cancer. Cancer, 70, 709-713.
31. NAYLOR MS, STAMP GWH AND BALKWILL FR. (1990). Investigation of cytokine gene expression in human colon cancer. Cancer Res., 50, 4436-4440.
32. NAYLOR MS, STAMP GW, FOULKES WD, ECCLES D AND BALKWILL FR. (1993). Tumour necrosis factor and its receptors in human ovarian cancer: potential role in disease progression. J. Clin. Invest., 91, 2194-2206.
33. NIEDBALA MJ AND PICARELLA MS (1992). Tumour necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by γ-interferon. Blood, 79, 678-687.
34. OPDENAKKER G AND DAMNE JV. (1992). Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer. Cytokine, 4, 251-258.
35. OROSZ P, ECHTENACHER B, FALK W, RÜSCHOFF J, WEBER D AND MANNEL DN. (1993). Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med., 177, 1391-1398.
36. PEKAREK LA, WEICHSELBAUM RR, BECKETT MA, NACHMAN J AND SCHREIBER H. (1993). Footprinting of individual tumors and their variants by constitutive cytokine expression patterns. Cancer Res., 53, 1978-1981.
37. PERLMUTTER DH, DINARELLO CA, PUNSAL PI AND COLTEN HR. (1986). Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J. Clin. Invest., 78, 1349-1354.
38. QUIN Z, KRÜGER-KRASAGAKES S, KUNZENDORF U, HOCK H, DIAMANTSTEIN T AND BLANKENSTEIN T. (1993). Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis. J. Exp. Med., 178, 355-360.
39. SCHALL TJ, LEWIS MM, KOLLER KJ, LEE A, RICE GC, WONG GHW, GATANAGA T, GRANGER GA, LENTZ R, RAAB H, KOHR WJ AND GOEDDEL D. (1990). Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell, 61, 361-370.
40. SCHLEEF RR, BEVILACQUA MP, SAWDEY M, GIMBRONE JR MA AND LOSKUTOFF DJ. (1988). Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem., 263, 5797-5803.
41. SIMS JE, MARCH KJ, COSMAN D, WIDMER MB, MACDONALD HR, MCMAHAN CJ, GRUBIN CE, WIGNALL JM, JACKSON JL, CALL SM, FRIEND D, ALPERT AR, GILLIS S, URDAL DL AND DOWER SK. (1988). cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science, 241, 585-589.
42. SIMS JE, ACRES B, GRUBIN CE, MCMAHAN CJ, WIGNALL JM, MARCH CJ AND DOWER SK. (1989). Cloning the interleukin 1 receptor from human T cells. Proc. Natl Acad. Sci. USA, 86, 8946-8950.
43. SIMS JE, GAYLE MA, SLACK JL, ALDERSON MR, BIRD TA, GIRI JG, COLOTTA F, RE F, MANTOVANI A, SHANEBECK K, GRABSTEIN KH AND DOWER SK. (1993). Interleukin 1 signaling occurs exclusively via the type 1 receptor. Proc. Natl Acad. Sci. USA, 90, 6155-6159.
44. SITRIN RG, TOD III RF, MIZUKAMI IF, GROSS TJ, SCHOLLENBERGER SB AND GYETKO MR. (1994). Cytokine-specific regulation of urokinase receptor (CD 87) expression by U937 mononuclear phagocytes. Blood, 84, 1268-1275.
45. SMITH CA, DAVIS T, ANDERSON D, SOLAM L, BECKMAN PM, JERZY R, DOWER SK. COSMAN D AND GOODWIN RG. (1990). A receptor for TNF defines an unusual family of cellular and viral proteins. Science, 248, 1019-1023.
46. TADA M, DISERENS AC, DESBAILLETS I AND DE TRIBOLET N. (1994). Analysis of cytokine receptor mRNA expressions in human glioblastoma cells and normal astrocytes by reverse transcription polymerase chain reaction. J. Neurosurg., 80, 1063-1073.
47. TARTAGLIA LA, PENNICA D AND GOEDDEL DV. (1993). Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem., 268, 18542-18548.
48. TRAN-THANG C, VOUILLAMOZ D, KRUITHOF EKO AND SORDAT B. (1994). Degradation of laminin by human colon carcinoma cells mediated by tissue-type plasminogen activator is cell-associated. J. Cell. Physiol., 161, 285-292.
49. VAN DER BOSCH J, RÜLLER E, ERNST M, SCHADE UF, MATHISON JC, RÜLLER S AND SCHLAAK M. (1992). Cytokines involved in monocyte mediated tumor cell death and growth inhibition in serum-free medium. J. Cell. Physiol., 152, 617-625.
50. VAN HINSBERGH VWM, VAN DEN BERG EA, FIERS W AND DOOIJEWAARD G. (1990). Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood, 75, 1991-1998.
51. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl Acad. Sci. USA, 83, 9679-9683.
52. VASSALLI P. (1992). The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol., 10, 411-452.
53. WALTZ DA, SAILOR LZ AND CHAPMAN HA. (1993). Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J. Clin. Invest., 91, 1541-1552.
54. YAMASAKI K, TAGA T, HIRATA Y, YAWATA H, KAWANISHI Y, SEED B, TANIGUCHI T, HIRANO T AND KISHIMOTO T. (1988). Cloning and expression of the human interleukin-6 (BSF-2/IFNβ 2) receptor. Science, 241, 825-828.